New patent expiration for Mylan Speclt drug PERFOROMIST
Annual Drug Patent Expirations for PERFOROMIST Perforomist is a drug marketed by Mylan Speclt and is included in one NDA. […]
New patent expiration for Mylan Speclt drug PERFOROMIST Read Post »
Patent Expiration
New patent expiration for Duchesnay drug DICLEGIS
Annual Drug Patent Expirations for DICLEGIS Diclegis is a drug marketed by Duchesnay and is included in one NDA. It
New patent expiration for Duchesnay drug DICLEGIS Read Post »
New patent expiration for Takeda Pharms drug INTUNIV
Annual Drug Patent Expirations for INTUNIV Intuniv is a drug marketed by Takeda Pharms Usa and is included in one
New patent expiration for Takeda Pharms drug INTUNIV Read Post »
New patent expiration for Merck Sharp drug CLARINEX D 24 HOUR
Annual Drug Patent Expirations for CLARINEX+D+24+HOUR Clarinex D 24 Hour is a drug marketed by Merck Sharp Dohme and is
New patent expiration for Merck Sharp drug CLARINEX D 24 HOUR Read Post »
New patent expiration for Merck Sharp drug CLARINEX-D 12 HOUR
Annual Drug Patent Expirations for CLARINEX-D+12+HOUR Clarinex-d 12 Hour is a drug marketed by Merck Sharp Dohme and is included
New patent expiration for Merck Sharp drug CLARINEX-D 12 HOUR Read Post »
New patent expiration for Merck Sharp drug CLARINEX
Annual Drug Patent Expirations for CLARINEX Clarinex is a drug marketed by Merck Sharp Dohme and is included in five
New patent expiration for Merck Sharp drug CLARINEX Read Post »
New patent expiration for Takeda Pharms drug OSENI
Annual Drug Patent Expirations for OSENI Oseni is a drug marketed by Takeda Pharms Usa and is included in one
New patent expiration for Takeda Pharms drug OSENI Read Post »
New patent expiration for Novartis drug TRILEPTAL
Annual Drug Patent Expirations for TRILEPTAL Trileptal is a drug marketed by Novartis and is included in two NDAs. It
New patent expiration for Novartis drug TRILEPTAL Read Post »
Drug Patent Expirations for the Week of June 13, 2021
OSENI (alogliptin benzoate; pioglitazone hydrochloride) Takeda pharms usa Patent: 6,329,404 Expiration: Jun 19, 2021 See More … For more information
Drug Patent Expirations for the Week of June 13, 2021 Read Post »
